RYR1 and Myalgia: RYR1 mutations can also induce malignant hyperthermia (MH), a potentially life‐threatening pharmacogenetic reaction to volatile anesthetics and muscle relaxants, as well as exertional rhabdomyolysis and myalgia (ERM).2, 3, 4